This small biotech could grow much larger with some good news from its pipeline.

Granted, revenue has still been higher over the past few years than it was before COVID-19, but the stock price is also down ...

West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug ...

TheFly reported on April 9 that Northland initiated coverage of SPRY with an Outperform rating and a $25 price target.

These companies boast significant upside potential.

The company's pipeline features almost 40 programs in late-stage clinical testing. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Tremfya.

The Indian Pharmaceutical Market (IPM) grew 10.1% year-on-year in March 2026, according to the report. Pricing contributed ...

Continue » Viking is a biotech company specializing in metabolic diseases. The company hasn't yet commercialized a drug, but ...

Organon (OGN) stock jumped 41% after Sun Pharmaceutical submitted a $12B all-cash acquisition offer, backed by JPMorgan and ...

In this article, we will be taking a look at the 7 Oversold Pharma Stocks to Buy Now. In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your trusted source for real-time updates and thorough analysis of a ...